EUVIMEDEUVIMED entdecken
Crossref

Omission of radiotherapy to lymph node level III in patients with cN0 adenoid cystic carcinoma of the major salivary gland: a single center experience

Zichen Qiu, Zheng Wu, Xiong Zhou, Yalan Tao, Yong Su

La radiologia medica · 2024

DOI: 10.1007/s11547-024-01763-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, 2024. Verfasst von Zichen Qiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-…. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Due to the rarity of adenoid cystic carcinoma (ACC) of the major salivary gland, there is no consensus on the extent of prophylactic neck irradiation (PNI) for patients with clinically negative lymph nodes (cN0) disease. MATERIALS AND METHODS: We conducted a retrospective analysis of all patients with ACC of the major salivary gland who received treatment at our center between January 2010 and April 2020. The primary endpoint was regional failure-free survival (RRFS). Secondary endpoints included overall survival (OS), distant metastasis-free survival (DMFS), local recurrence-free survival (LRFS), and acute toxicity. RESULTS: A total of 139 patients were included in the analysis. For cN0 patients, the 5-year RRFS, OS, DMFS, and LRFS were 93.2%, 90.2%, 75.7%, and 91.4%, respectively. Multivariate analysis revealed that PORT was an independent prognostic factor for RRFS and LRFS. No statistically significant differences were observed between the Level III sparing PNI group and the Standard PNI group in terms of RRFS, OS, DMFS, and LRFS. The doses delivered to the larynx and thyroid in the Level III sparing PNI group were significantly lower than those in the Standard PNI group. CONCLUSION: In patients with cN0 ACC of the major salivary gland, PNI improves regional control, and the level III nodal region sparing radiotherapy does not increase the risk of level III recurrence, while potentially reducing toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticSalivary Gland NeoplasmsHumansRetrospective StudiesSalivary GlandsLymph Nodes

Stichwörter der Autor:innen

Adenoid cystic carcinoma of the major salivary glandClinically negative lymph nodes diseaseIntensity-modulated radiotherapyProphylactic neck irradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Yuexiu District,…
  • Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 283 Tong Zi Po Road, Changsha, 410013, People's Republic of China.

Zitieren

APA

Qiu, Z., Wu, Z., Zhou, X., Tao, Y., & Su, Y. (2024). Omission of radiotherapy to lymph node level III in patients with cN0 adenoid cystic carcinoma of the major salivary gland: a single center experience. La radiologia medica. https://doi.org/10.1007/s11547-024-01763-5

Vancouver

Qiu Z, Wu Z, Zhou X, Tao Y, Su Y. Omission of radiotherapy to lymph node level III in patients with cN0 adenoid cystic carcinoma of the major salivary gland: a single center experience. La radiologia medica. 2024. doi:10.1007/s11547-024-01763-5

BibTeX
@article{Qiu2024,
  author = {Qiu, Zichen and Wu, Zheng and Zhou, Xiong and Tao, Yalan and Su, Yong},
  title = {Omission of radiotherapy to lymph node level III in patients with cN0 adenoid cystic carcinoma of the major salivary gland: a single center experience},
  journal = {La radiologia medica},
  year = {2024},
  doi = {10.1007/s11547-024-01763-5}
}
Kostenlos starten →